NL-201

FDA sideswipes Neoleukin with clinical hold on lead immunotherapy candidate, sends shares plummeting
Endpoints
Fri, 01/8/21 - 09:34 am
Neoleukin
NL-201
FDA
natural killer cell therapy
oncology
clinical trials